Incidence Of Intramammary Infection Research Articles

Periparturient blood T-lymphocyte PD-1 and CTLA-4 expression as potential predictors of new intramammary infections in dairy cows during early lactation (short communication)

BackgroundThe periparturient period in dairy cows is marked by immunosuppression which increases the likelihood of infectious disorders, particularly also mastitis. An in-depth understanding of peripartum leukocyte biology is vital for the implementation of highly successful post-partum disease prevention measures. Immune checkpoint molecules, such as programmed death 1 (PD-1) and cytotoxic T-lymphocyte antigen 4 (CTLA-4), are critical inhibitory receptors expressed on immune cells, particularly T cells, that drive immunosuppressive signaling pathways. However, the potential role of immune checkpoint molecules expression in T-cells on udder health has never been explored. Thus, the association between the occurrence of new postpartum intramammary infections (IMIs) and the expression of programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) on blood T-cells during the peripartum period was investigated.ResultsIn this study, the incidence of IMIs by any pathogen in early lactation was not associated with a higher expression of PD-1 and CTLA-4 in the periparturient period. However, the incidence of IMIs by major pathogens throughout the first month of lactation was significantly associated with higher expression of PD-1 at 14 days before calving (P = 0.03) and CTLA-4 at parturition (P = 0.03) by blood T-cells. Also, the expression of CTLA-4 at D0 (P = 0.012) by T-cells was associated with the occurrence of persistent IMIs during the first month of lactation.ConclusionsTo our knowledge, this is the first report to investigate the expression of PD-1 and CTLA-4 by blood T-lymphocytes during the periparturient period in dairy cows and to explore their relationship with the incidence of new IMIs in the postpartum period. Thus, a comprehensive understanding of leukocyte biology during peripartum would appear to be a prerequisite for the identification of resilient dairy cows or targets innovative (immunological) non-antibiotic approaches in the transition period.

Strategic administration of antioxidant multiminerals and vitamins to transitional buffaloes augments antioxidant and udder defense mechanisms in early lactation

The aim of the study was to examine the effects of repeated administrations of antioxidant multiminerals and vitamins in transition buffaloes on udder defense mechanism, antioxidant activity and occurrence of intramammary infection (IMI) in early lactation period. Forty clinically healthy pregnant buffaloes were enrolled 45 days before expected date of calving and randomly allocated into five different supplementation groups (n = 8): only basal ration (control), vitamin E and selenium (VES), multiminerals (MM), ascorbic acid (AA) and chromium (Cr) picolinate in basal diet. The udder defense mechanism was monitored by measuring phagocytic activity (PA), myeloperoxidase (MPO) and nitric oxide (NO) productions in milk leukocytes, antioxidant activity was evaluated by measuring total antioxidant capacity (TAC) in plasma and occurrence of IMI was assessed by milk cytology, bacterial count in milk and visible clinical signs of udder until day 28 post-calving. The results showed that the VES and MM supplementations exhibited significantly higher PA, MPO and NO productions of milk leukocytes till first week of lactation whereas, elevated mean TAC in plasma was maintained from day −7 to 1 of calving in MM supplementation group as compared to control group. Statistically, no significant difference in occurrences of subclinical or clinical IMI was noted across the groups until four weeks of lactation. Taken together, it is concluded that repeated administrations of VES and MM to transition buffaloes could be an effective strategy to maintain good udder health by augmenting milk leukocyte functions and antioxidant status and preventing incidence of IMI in early lactation.

Associations of cow- and herd-level factors during the dry period with indicators of udder health in early-lactation cows milked by automated milking systems

This observational study aimed to determine the association of cow-level factors and herd-level housing and management practices during the dry period with indicators of udder health in early-lactation cows in automated milking system (AMS) herds. Data were collected from 166 commercial AMS dairy farms (mean ± standard deviation = 116 ± 111 milking cows; range = 39 to 1,200) across Canada between October 2018 and September 2020. Information on herd demographics, housing, and management practices was obtained on each farm using 2 surveys. On each farm, we selected all cows that had available Dairy Herd Improvement (DHI) somatic cell count (SCC) data for their last milk test before dry-off (>250 d in milk) and their first milk test after calving (5-45 d in milk). Data from 14,007 cows were included after excluding cows with a dry period of <30 d and >120 d. Using the SCC data, we calculated for each cow the somatic cell score (SCS) for the last milk test before dry-off (PreSCS) and the first milk test after calving (PostSCS), which we then averaged per herd at a test-day level. Intramammary infection (IMI) was estimated using cow SCC data. Each cow was classified as not infected (SCC <200,000 cells/mL) or infected (SCC ≥200,000 cells/mL) at her last milk test before dry-off and her first milk test after calving. Based on this classification, cows were further categorized as never infected, always infected, new IMI, or cured IMI. At the cow level, a higher PostSCS was associated with longer dry periods. The odds of having a new IMI were higher for cows of higher parity and that had lower 305-d milk yield before dry-off. Cows with lower parity were more likely to cure an IMI. At the herd level, a higher 305-d milk yield before dry-off was associated with a lower incidence of new IMI and a higher incidence of cured IMI. Separating cows into a different pen as preparation for dry-off tended to be associated with a lower PostSCS and incidence of new IMI. At dry-off, herds that used teat sealants and blanket antibiotic dry cow therapy also had lower PostSCS. During the dry period, housing cows in different groups was associated with a higher PostSCS and a lower incidence of cured IMI, while housing cows in both pack pens and stalls compared with only pack pens was associated with a lower incidence of new IMI. Finally, placing cows onto the AMS to be milked one or more days after calving tended to be associated with a lower PostSCS compared with placing them in the AMS within the first day postpartum. In summary, indicators of udder health in early-lactation cows in AMS herds were associated with several cow-level factors and herd-level housing and management practices before dry-off, at dry-off, during the dry period, and at the beginning of lactation. Thus, if some of the associations identified are causal, AMS producers may be able to improve udder health through modifications of housing and management practices.

To seal or not to seal following an antimicrobial infusion at dry-off? A systematic review and multivariate meta-analysis of the incidence and prevalence of intramammary infections post-calving in dairy cows

Teat sealants (TSs) consist of sterile formulations with no antibacterial activity. Alone or in combination with antimicrobial (AM) or non-AM treatments, TSs have been commonly used in dairy cows at dry-off to prevent intra-mammary infections (IMIs) during the dry period. This study aimed to identify and synthesise the available evidence on the efficacy of combining TSs with AM treatments on the incidence and prevalence of IMIs. A comprehensive search of three electronic databases, two relevant conference proceedings, and reference lists of reviews and eligible articles was conducted to retrieve and identify studies that could answer the following question: in dairy cows, how does the efficacy of an AM–TS combination administered at dry-off compare with an AM alone for preventing new IMI? In addition to the general IMIs, bacterial species-specific data were extracted and combined into nine distinct pathogen groups: coagulase-positive and negative staphylococci; S. dysgalactiae; non-dysgalactiae Streptococci; E. coli; non-E. coli Enterobacteriaceae; Corynebacterium spp.; yeast and other frequent mastitis pathogens. The structural relationship between each study's prevalence and incidence, as the new (incidence) and persistent (uncured) infections make up the prevalence, was utilised to approximate a variance-covariance matrix for the within-study correlation between their study-specific log odds ratios (ORs). A bivariate random-effects meta-analysis was employed, utilising the within- and between-study correlations to synthesise both outcomes simultaneously. The risk of bias was assessed using the Cochrane ROBINS-I tool, and the quality of the body of evidence was rated using the GRADE approach. A total of 17 trials (16 studies), providing either IMIs incidence (n = 4), prevalence (n = 3) or both (n = 10), were identified. Overall, quarters infused with AM-TS combinations showed lower odds of new IMIs post-calving (OR=0.70; 95% CI=0.57–0.86; Wald test P < 0.001) than those which received only AMs. Across the pathogen groups, varying levels of reduction of new IMIs were found, where administration of TSs was most effective against S. dysgalactiae (OR=0.47; 95% CI=0.23–0.98), non-dysgalactiae streptococci (OR=0.60; 95% CI=0.49–0.74), E. coli (OR=0.62; 95% CI=0.50–0.77), Corynebacterium spp. (OR=0.68; 95% CI=0.52–0.90) and coagulase-negative staphylococci (OR=0.85; 95% CI=0.76–0.94). However, additional TS infusion did not significantly reduce new IMIs in the remaining pathogen groups. The current meta-analytic evidence supports the efficacy of using TS add-on infusions in dairy cows at dry-off for reducing the incidence and prevalence of IMIs post-calving; however, pathogen group differences should be considered.

Drying-off dairy cows without antibiotic therapy and orally supplemented with lyophilized Aloe arborescens: effects on rumen activity, immunometabolic profile, and milk yield.

The drying-off is a stressful stage of the lactation cycle of dairy cows that deeply affects cows' metabolism, inflammatory status, and immune system. The promising effects observed during the transition period resulting from supplementation with Aloe arborescens Mill. suggest its potential utility during this phase. A group of 23 Holstein dairy cows with somatic cell count (SCC) less than 200 × 103 cells/ml and without intramammary infections were enroled in the study. Cows were divided into two groups: one orally receiving 10 g/day of A. arborescens Mill. lyophilized powder (AL; 11 cows) between -7 and 7 days from dry-off (DFD), and a control group (CTR; 12 cows). From -14 to 7 DFD and 7 and 28 days from calving, the body condition score and rectal temperature were determined, and rumen fluid, feces, milk, and blood samples were collected. Daily rumination times and milk yield were recorded. Data were analyzed through repeated measures mixed models. Compared to the CTR group, AL cows tended to show reduced production of volatile fatty acids in the rumen with acetate proportion that tended to be higher and valerate proportion that was lower. Moreover, Aloe supplementation caused a reduction in fecal dry matter. At the end of drying-off, AL cows presented better liver function, as suggested by higher paraoxonase plasma concentrations at 7 DFD, higher glucose, and lower urea, but showed increased reactive oxygen metabolites. Aloe supplementation at dry-off ameliorated inflammatory status after calving (lower haptoglobin and ceruloplasmin levels), and improved milk yield in the first weeks of subsequent lactation, without influencing milk composition, SCC, and incidence of intramammary infections. These results confirmed the positive effects of Aloe administration on liver function in dairy cows but indicate the need for further studies investigating the effects of Aloe on rumen fermentation profile and oxidative status.

The effectiveness of an internal teat sealant in preventing new intra mammary infections in dairy cattle during dry period

The aim of our study was to evaluate the effect of an internal teat sealant infused upon drying off on the incidence of new intra-mammary infections (IMI) during the dry period in dairy cattle. Due to the non-availability of the product on the Indian market, the product was prepared in a laboratory using bismuth subnitrate and liquid paraffin. A total of 64 quarters free from infection on culture were selected for the study at 60 days before the expected date of parturition. The quarters were randomly divided into two groups (group A and group B), with 32 quarters in each group. The group A quarters were infused with teat sealant at the time of drying off, and the quarters in group B were kept as the control and no treatment was provided to them. Milk samples from all the selected quarters were subjected to cultural examination at the time of drying off and 1-3 days post calving. The incidence of new IMI’s between drying off and calving was significantly lower for group A quarters when compared to group B quarters (12.5% vs 34.4%). The incidence of new IMI’s in group A and group B quarters was significantly lower for Streptococcus uberis (3.13% vs 18.75%) and Streptococcus dysgalactiae (3.13% vs 12.5%). The study concluded that infusion of teat sealant at drying off is helpful in lowering the incidence of new IMI’s during the dry period.

Comparative efficacy of antimicrobial treatments in dairy cows at dry-off to prevent new intramammary infections during the dry period or clinical mastitis during early lactation: a systematic review and network meta-analysis.

A systematic review and network meta-analysis were conducted to assess the relative efficacy of antimicrobial therapy given to dairy cows at dry-off. Eligible studies were controlled trials assessing the use of antimicrobials compared to no treatment or an alternative treatment, and assessed one or more of the following outcomes: incidence of intramammary infection (IMI) at calving, incidence of IMI during the first 30 days in milk (DIM), or incidence of clinical mastitis during the first 30 DIM. Databases and conference proceedings were searched for relevant articles. The potential for bias was assessed using the Cochrane Risk of Bias 2.0 algorithm. From 3480 initially identified records, 45 trials had data extracted for one or more outcomes. Network meta-analysis was conducted for IMI at calving. The use of cephalosporins, cloxacillin, or penicillin with aminoglycoside significantly reduced the risk of new IMI at calving compared to non-treated controls (cephalosporins, RR = 0.37, 95% CI 0.23-0.65; cloxacillin, RR = 0.55, 95% CI 0.38-0.79; penicillin with aminoglycoside, RR = 0.42, 95% CI 0.26-0.72). Synthesis revealed challenges with a comparability of outcomes, replication of interventions, definitions of outcomes, and quality of reporting. The use of reporting guidelines, replication among interventions, and standardization of outcome definitions would increase the utility of primary research in this area.

Comparative efficacy of teat sealants given prepartum for prevention of intramammary infections and clinical mastitis: a systematic review and network meta-analysis.

A systematic review and network meta-analysis were conducted to assess the relative efficacy of internal or external teat sealants given at dry-off in dairy cattle. Controlled trials were eligible if they assessed the use of internal or external teat sealants, with or without concurrent antimicrobial therapy, compared to no treatment or an alternative treatment, and measured one or more of the following outcomes: incidence of intramammary infection (IMI) at calving, IMI during the first 30 days in milk (DIM), or clinical mastitis during the first 30 DIM. Risk of bias was based on the Cochrane Risk of Bias 2.0 tool with modified signaling questions. From 2280 initially identified records, 32 trials had data extracted for one or more outcomes. Network meta-analysis was conducted for IMI at calving. Use of an internal teat sealant (bismuth subnitrate) significantly reduced the risk of new IMI at calving compared to non-treated controls (RR = 0.36, 95% CI 0.25-0.72). For comparisons between antimicrobial and teat sealant groups, concerns regarding precision were seen. Synthesis of the primary research identified important challenges related to the comparability of outcomes, replication and connection of interventions, and quality of reporting of study conduct.

Staphylococcal intramammary infection dynamics and the relationship with milk quality parameters in dairy goats over the dry period

The objectives of this study were (1) to report the rates of new intramammary infection (IMI) and spontaneous IMI cure over the dry period in 3 dairy goat herds; (2) to evaluate the factors predicting infection dynamics over the dry period; and (3) to define milk quality parameter thresholds that predict infection dynamics over the dry period. Two consecutive udder-half milk samples were collected 10 to 14 d apart before dry-off from 288 goats in 3 herds, and 2 consecutive udder-half samples were collected 7 to 14 d apart in the following lactation, with the first sample being collected ≤10 d in milk, from 200 of the same goats. In 2 of the herds, udder-half milk samples were also collected at the same time points (n = 312 halves; 157 goats) for measurement of milk quality parameters. Standard aerobic culture of milk samples was performed for the detection of mastitis pathogens. To rule out the presence of Mycoplasma spp. IMI, milk samples were also cultured on modified Hayflick medium. Non-Mycoplasma isolates were speciated using MALDI-TOF mass spectrometry. Staphylococcal isolates, when not identified by MALDI-TOF, were speciated using partial gene sequence analysis of rpoB or tuf. When >1 sample from an udder half yielded the same species, available isolates from the first and last positive samples for that species were strain-typed using pulsed-field gel electrophoresis. Incidence of new IMI and cure rate were computed. Generalized linear mixed regression models were built to evaluate the associations between new IMI and pre-dry somatic cell score (SCS), between IMI persistence and half-level SCS, and between IMI persistence and pre-dry IMI species. Thresholds for pre-dry SCS and lactose concentration were computed to predict IMI persistence. Overall, 12.6% (48/380) of halves had a persistent IMI. Cumulative incidence of new IMI over the dry period was 13.2%, and cure rate was 52.0%. Pre-dry SCS was not associated with odds of new IMI or IMI persistence. Pre-dry IMI species was not associated with odds of persistence. Lactose concentration was not associated with odds of persistence. Regardless of culture data, the optimal pre-dry SCS threshold to detect IMI that would persist into the next lactation was 8.7, with sensitivity and specificity of 50 and 73.8%, respectively. Further studies on the effect of control measures on species-specific incidence and cure rates during the dry period are warranted.

Investigation of the relationship between bedding materials, bedding characteristics, and intramammary infection in late lactation dairy cows

Many cows acquire subclinical intramammary infections (IMI) during lactation, necessitating antimicrobial treatment at dry-off (dry cow therapy). If the dairy industry moves toward the adoption of selective dry cow therapy, one essential strategy to reduce mastitis-associated antimicrobial use at dry off will be to reduce the incidence of new IMI during lactation. One important source of mastitis-causing pathogens is bedding. However studies are needed to investigate the association between bedding management, bedding bacteria count (BBC), and IMI risk in late lactation cows.&#x0D; The objectives of this prospective cross-sectional study are to: 1) describe associations between BBC and IMI prevalence for individual pathogens and specific pathogen groups in late lactation cows, 2) identify bedding-related risk factors for high BBC, and 3) identify critical levels of bacteria in bedding that might be used as cut-points to guide practitioners when interpreting BBC reports. This study is ongoing, with winter 2018 results currently being assembled.

Factors associated with intramammary infection in dairy cows caused by coagulase-negative staphylococci, Staphylococcus aureus, Streptococcus uberis, Streptococcus dysgalactiae, Corynebacterium bovis, or Escherichia coli

The aim of this study was to determine risk factors for bovine intramammary infection (IMI) associated with the most common bacterial species in Finland. Large databases of the Finnish milk-recording system and results of microbiological analyses of mastitic milk samples from Valio Ltd. (Helsinki, Finland) were analyzed. The study group comprised 29,969 cows with IMI from 4,173 dairy herds. A cow with a quarter milk sample in which DNA of target species was detected in the PathoProof Mastitis PCR Assay (Thermo Fisher Scientific, Waltham, MA) was determined to have IMI. Only cows with IMI caused by the 6 most common pathogens or groups of pathogens, coagulase-negative staphylococci (CNS), Staphylococcus aureus, Streptococcus uberis, Streptococcus dysgalactiae, Corynebacterium bovis, and Escherichia coli, were included. The control group comprised 160,176 IMI-free cows from the same herds as the study group. A multilevel logistic regression model was used to study herd- and cow-specific risk factors for incidence of IMI. Pathogen-specific results confirmed those of earlier studies, specifically that increasing parity increases prevalence of IMI regardless of causative pathogen. Holsteins were more susceptible to IMI than Nordic Reds except when the causative pathogen was CNS. Occurrence of IMI caused by C. bovis was not related to milk yield, in contrast to IMI caused by all other pathogens investigated. Organic milk production was associated with IMI only when the causative pathogen of IMI was Staph. aureus; Staph. aureus IMI was more likely to occur in conventional than in organic production. Cows in older freestall barns with parlor milking had an increased probability of contracting an IMI compared with cows in tiestall barns or in new freestall barns with automatic milking. This was the case for all IMI, except those caused by CNS, the prevalence of which was not associated with the milking system, and IMI caused by Staph. aureus, which was most common in cows housed in tiestall barns. A better breeding index for milk somatic cell count was associated with decreased occurrence of IMI, indicating that breeding for improved udder health has been successful in reducing the incidence of IMI caused by the most common pathogens in Finland. In the Finnish dairy sector, the importance of other measures to control IMI will increase as the Holstein breed progressively takes the place of the Nordic Red breed. Attention should be paid to hygiene and cleanliness, especially in old freestall barns. Based on our results, the increasing prevalence of automatic milking is not a reason for special concern.

Randomised controlled trials demonstrate efficacy of a novel internal teat sealant to prevent new intramammary infections in dairy cows and heifers

AIMS: The main aim was to investigate the effectiveness of a novel internal teat sealant (ITS) formulation containing bismuth subnitrate and the antiseptic chlorhexidine, in adult cows (Trial A) and nulliparous heifers (Trial B), to reduce the incidence of new intramammary infection (IMI) between treatment and calving and reduce the prevalence of IMI within 6 days following calving.METHODS: In Trial A dairy cows (n=326) without history of clinical mastitis and with a maximum composite milk somatic cell count <200,000 cells/mL during the current lactation were enrolled from three spring-calving mainly pasture-based herds immediately following the final milking. In Trial B all heifers (n=166) were enrolled from two herds approximately 3 weeks before the start of calving. Glands were randomly assigned to controls or treatment with ITS, and mammary secretion samples were taken from all glands prior to treatment, and on two occasions 0–4 and 3–6 days post-calving to determine the incidence of new IMI and the prevalence of IMI immediately post-calving. Additionally, cows in Trial A were monitored for cases of clinical mastitis (CM) in the non-lactating period and animals in both trials were monitored for cases of CM within 30 days of calving.RESULTS: The ITS reduced the estimated incidence of new IMI with both major and any pathogens compared to control glands in cows (6.2 vs. 14.2% and 14.7 vs. 32.8%, respectively) and in heifers (3.0 vs. 13.1% and 13.4 vs. 25.3%, respectively) (p<0.001). The ITS reduced the estimated prevalence of a major or any pathogen compared to untreated controls at both 0–4 and 3–6 days post-calving, in both cows and heifers. Additionally, the ITS reduced the incidence of CM in the non-lactating period in cows (−1.0%, p=0.01) and in the 30 days following calving in heifers (−2.0%, p=0.06), and tended to reduce the estimated incidence of CM in cows post-calving (−1.7%, p=0.10).CONCLUSIONS: The novel ITS reduced the incidence of new IMI, and the prevalence of IMI at calving in both adult cows and heifers, and reduced the incidence of CM in the non-lactating period of cows and in the first 30 days after calving in heifers.CLINICAL RELEVANCE: The results of these trials demonstrate the efficacy of a novel ITS for the control of mastitis in likely uninfected dairy cows over the non-lactating period and in heifers in late pregnancy.

Relationship between postmilking standing duration and risk of intramammary infection in freestall-housed dairy cows milked 3 times per day

Recent evidence exists to suggest that the risk of subclinical mastitis, particularly those infections caused by environmental pathogens, in dairy cows is related to standing and lying patterns. The objective of this study was to determine the association between postmilking standing duration (PMSD) of dairy cows milked 3×/d and risk of intramammary infection (IMI). Four commercial freestall dairy herds in Eastern Ontario, milking 3×/d, were enrolled in a longitudinal study. Forty Holstein-Friesian cows per herd were randomly selected as focal animals from those cows in each herd that met our selection criteria of days in milk (<200 d) and somatic cell count (<100,000cells/mL). The study consisted of three 28-d periods. The study began following a regularly scheduled Dairy Herd Improvement test with the collection of quarter-level milk samples from all focal animals. Bacteriology was used to confirm infection status at the start of the study and for determination of incidence of IMI throughout the study. A new IMI was defined as having a culture-positive quarter-level sample when the previous sample (28 d prior) had been culture negative for the pathogen of interest. Four sets of quarter-level milk samples were obtained for each focal animal. Lying behavior was recorded for 5 d after each milk sampling using data loggers. For these 5 d, individual milking times, production, and feeding times were also recorded. Postmilking standing duration was analyzed by milking event, with increased PMSD being positively associated with provision of fresh feed or freshly pushed-up feed around the time of milking, greater feed bunk space per cow, and lower freestall stocking density. Over the study period, 456 new IMI were detected, resulting in a mean herd incidence rate of 3.22 IMI per quarter year. Coagulase-negative staphylococci (CNS) and Corynebacterium spp. IMI were statistically analyzed to determine relationship with PMSD; they were the 2 predominant pathogens representing 45 and 31% of IMI, respectively. Only CNS IMI was associated with PMSD. A nonlinear relationship between PMSD and incidence of CNS IMI was found; cows with a PMSD of 90 to 120min were at a reduced risk for CNS IMI. The risk of experiencing CNS IMI was also reduced with increased frequency of feed push-ups and provision of fresh feed 60min before to 90min after milking and >540min after milking. These results indicate that management practices that promote PMSD of 90 to 120min, such as the provision of fresh feed or freshly pushed-up feed around the time of milking, providing ample feed bunk space per cow, and keeping freestall stocking density low, should be encouraged to reduce the risk of CNS IMI in freestall-housed cows milked 3×/d.

Prevalence and incidence of intramammary infections in lactating dairy goats

AIM: To determine the prevalence of intramammary infection (IMI) of lactating dairy goats between 0 and 4 days postpartum, the prevalence and incidence rate of new IMI at Weeks 2, 14 and 27 of lactation, and the relationship between herd-level prevalence of IMI and bulk tank somatic cell count (BTSCC).METHODS: Milk samples were collected from 8% of a herd (total 624 does) from 18 dairy goat herds in the Waikato region of New Zealand, for bacteriology and somatic cell count (SCC) determination, from both glands within 4 days of kidding (Week 0) and again at Weeks 2, 14 and 27. Prevalence of IMI was determined at each time point and incidence rate calculated for Weeks 0–2, 2–14, and 14–27. Greenwood and Reed-Frost models were compared for estimation of the transmission parameter for all pathogens, and for Staphylococcus aureus, coagulase negative staphylococci (CNS) and Corynebacterium spp. separately.RESULTS: Bacteria were isolated from 1,122/4,814 (23.3%) glands, with CNS (13.4%) and Corynebacterium spp. (7.3%) being the most common isolates. Prevalence of any IMI increased with stage of lactation, varied among herds, and increased with age (all p<0.05). Incidence rate was 80, 24 and 7 new IMI/10,000 gland days for Weeks 0–2, 2–14 and 14–27, respectively. Incidence rate for any IMI increased with age and with the presence of an IMI in the contralateral gland, and varied among herds (p<0.001). The transmission of each pathogen was better modelled assuming contagiousness (Reed-Frost models), than not (Greenwood models).At gland level, IMI increased SCC at all stages of lactation (p<0.001). The gland prevalence of IMI within herds was positively associated with ln BTSCC at Week 2 (p=0.02), but not Weeks 14 or 27 (p>0.05).CONCLUSIONS: Prevalence of IMI increased with stage of lactation, but the highest incidence rate of new IMI occurred in early lactation. Models accounting for the contagious nature of infection fitted better than those not accounting for contagiousness. BTSCC was only associated with prevalence of IMI in early lactation.CLINICAL RELEVANCE: Reduction of BTSCC in dairy goats may be best achieved by minimising the prevalence and incidence of new IMI in early lactation. Further studies are required to define management factors associated with the between herd, and stage of lactation, effects on prevalence and incidence rate in order to reduce BTSCC throughout lactation.

The effect of internal teat sealant products (Teatseal and Orbeseal) on intramammary infection, clinical mastitis, and somatic cell counts in lactating dairy cows: A meta-analysis

The objective of this study was to assess the efficacy of internal teat sealant products containing bismuth subnitrate (Teatseal and Orbeseal; Pfizer Animal Health, West Ryde, Australia) when used alone, or in the presence of antibiotic dry cow therapy (ADCT), before or at drying off on the incidence of new intramammary infections (IMI), clinical mastitis, and milk somatic cell count (SCC) during lactation. The literature search identified 18 English-language publications on the use of Teatseal in dairy cattle. A total of 12 studies with 17 subtrials or comparisons including 13 positive control subtrials (internal teat sealant and ADCT vs. ADCT) and 4 negative control subtrials (internal teat sealant vs. untreated) examining IMI were included in the analysis. Internal teat sealants, alone or in the presence of ADCT, reduced the risk of acquiring new IMI after calving by 25% [risk ratio (RR)=0.75; 95% confidence interval (CI): 0.67 to 0.83]. Internal teat sealants reduced the risk of IMI by 73% compared with untreated cows (RR=0.27; 95% CI: 0.13 to 0.55). The results of both meta-analyses of IMI, with positive and negative controls, were heterogeneous [I2 (a statistic that describes the proportion of total variation in study effect estimates that is due to heterogeneity)=65.4 and 92.1%]. No farm or cow factors studied significantly contributed to the heterogeneity of the results. A total of 16 studies (21 subtrials), including 14 positive control subtrials and 7 negative control subtrials, examining clinical mastitis were included in the analysis. Internal teat sealants alone and in the presence of ADCT reduced the risk of clinical mastitis after calving in lactating cows by 29% (RR=0.71; 95% CI: 0.62 to 0.82), and 48% (RR=0.52; 95% CI: 0.37 to 0.75), respectively. The results of the meta-analysis on clinical mastitis with positive controls were homogeneous (I2=33.6%), whereas the results of studies with negative controls were heterogeneous (I2=60.4%). No farm or cow factors studied that had sufficient data to evaluate significantly contributed to the heterogeneity of the results. The estimated linear score (LS) of milk SCC after calving in published studies (n=3) and for studies that provided raw data (n=2), was significantly lower for cattle treated with internal teat sealants and ADCT in 3 studies than for cattle treated with internal teat sealants only. The estimated LS of pooled raw data of 3 studies from 32 herds showed that the LS of cows treated with internal teat sealant and ADCT was not significantly different than those treated with ADCT only. This study found that the application of internal teat sealants in the presence of ADCT or the use of internal teat sealants alone at dry off significantly reduced the incidence of IMI and clinical mastitis in lactating dairy cows compared with respective control groups. Further studies are needed to investigate the effect of internal teat sealants on postpartum milk SCC in lactating dairy cows.

The effect of intramammary infection with coagulase-negative staphylococci in early lactating heifers on milk yield throughout first lactation revisited

The objective of this study was to further scrutinize the previously found positive association between intramammary infection (IMI) caused by coagulase-negative staphylococci (CNS) in early lactating heifers and test-day daily milk yield (MY) throughout first lactation, with a specific focus on the effect of the heifers’ genetically determined milk production levels and the incidence of clinical mastitis. Two precise longitudinal data sets were analyzed using a series of statistical models including potential confounding and intermediate variables. The final database included the IMI status at calving, composite milk somatic cell count (SCC) and MY records at test day up to 285 d in milk (DIM), farmer-recorded clinical mastitis (CM) cases between 14 and 285 DIM, estimated new IMI incidence based on a SCC threshold of 100,000cells/mL between 14 and 285 DIM, DIM, average 305-d MY at the herd level, and the heifers’ genetic merit for MY from 240 dairy heifers from 29 dairy herds. Seventy-one (29.6%) early lactating heifers were noninfected, 108 heifers (45.0%) were CNS infected, and 61 heifers (25.4%) were infected with any major pathogen. The positive effect of CNS IMI in early lactation on test-day MY was estimated at 1.32kg/d using a first basic mixed regression model. Correcting for the confounder genetic merit for MY reduced this effect to 1.17kg. Interestingly, taking into account the confounding effect of herd resulted in an increase of the estimate from 1.32 to 2.2kg/d. The positive effect of CNS IMI in early lactation on MY after correcting the model for both confounders was estimated at 2.05kg/d. Heifers infected with CNS in the first DIM tended to have fewer CM cases throughout lactation compared with the noninfected herd mates. Including the intermediate variable CM in the model explained 0.16kg/d of the corrected effect of 2.05kg/d. Inclusion of test-day SCC, another intermediate variable, however, increased the estimate by 0.11kg/d. With an appropriate correction for several confounders and biologically understood intermediate variables such as CM, test-day SCC, and new IMI based on SCC threshold of 100,000cells/mL, an unexplained test-day MY difference between CNS-infected and noninfected heifers of 2.0kg/d remained.

Effect of disinfecting teats post-milking or pre- and post-milking on intramammary infection and somatic cell count

AIMS: To determine the effects of (a) post-milking teat disinfection compared with no disinfection and (b) pre- and post-milking teat disinfection compared with post-milking disinfection alone, on the incidence of new intramammary infection (IMI), somatic cell count (SCC) and teat skin abnormalities in dairy cows. METHODS: In Experiment 1, dairy cows in five dairy herds were randomly allocated to a post-milking teat disinfection group (n=230), that was sprayed with an iodine-based disinfectant (TeatguardPlus) for a complete lactation, or to a non-disinfected group (n=239). In Experiment 2, cows were randomly allocated to post-milking teat disinfection (n=239) or both pre- and post-milking teat disinfection (n=235), using a chloramine-T-based disinfectant (Teatsweet) for both treatments, from calving to 118–127 days in milk. The incidence of new IMI was determined by aseptic sampling of all quarters at calving, during lactation, and at trial end or at drying-off, with clinical mastitis cases sampled on detection. SCC and teat skin abnormalities were measured at 2-monthly intervals during lactation. In both experiments, disinfectant was applied by spray application. RESULTS: Cows that received post-milking teat disinfection had a lower incidence of new IMI caused by Staphylococcus aureus, Streptococcus uberis, Corynebacterium spp and coagulase negative staphylococci, had lower bulk milk SCC during lactation, and had fewer teat skin abnormalities compared with the non-disinfected cows (p < 0.05). Pre-milking teat disinfection, in addition to post-milking teat disinfection, did not reduce the incidence of new IMI for any pathogens and did not reduce SCC (p> 0.05). CONCLUSIONS: Post-milking teat disinfection applied as a spray is a key component in mastitis control in New Zealand. There was no benefit from the addition of pre-milking disinfection. CLINICAL RELEVANCE: This study confirms previous findings of the effectiveness of post-milking teat disinfection in reducing the incidence of IMI caused by the common mastitis-causing pathogens in New Zealand, and presents the first results of a controlled study examining pre-milking teat spraying undertaken in New Zealand commercial dairy herds.

Monitoring herd incidence of intramammary infection in lactating cows using repeated longitudinal somatic cell count measurements

The objective of the study was to evaluate the ability of an estimate of the herd intramammary infection (IMI) incidence rate computed using repeated somatic cell count (SCC) measurements (quarter- and composite-SCC; hereafter, the SCC-derived herd IMI incidence, SCCI)to predict the incidence rate computed using repeated quarter-milk bacteriological culture (hereafter, bacteriological culture incidence, BCI) during the lactating period. A cohort of 91 Canadian dairy herds was followed in 2007 and 2008. In each herd and at each of 4 sampling periods, a series of 3 to 7 quarter-milk samples was collected from a sample of 15 cows. Routine milk bacteriological culture was conducted to identify IMI, SCC was measured on the quarter-milk samples, and composite-SCC of the preceding and following dairy herd improvement (DHI) tests were obtained. Mastitis pathogens were grouped in 3 categories: major, minor, and any pathogens. For each herd and for each period, BCI was computed for each group of organisms. Similarly, SCCI were computed using quarter- and DHI composite-SCC and using a threshold of 200,000 cells/mL to define infected quarters or cows. A linear regression model taking into account the structure of the data was used to compare the SCCI to the BCI. A similar model was used to compare fluctuations (i.e., changes from one sampling period to the next) over time of the SCCI and BCI. Measures of correlation between observed and predicted rates were computed and limits of agreement plots sketched to better explore the predictive ability of the SCCI. The quarter-milk SCC measurements that could be obtained—for instance, using on-line milking system measurements—appeared to be particularly valuable. Quarter-SCCI showed a positive and significant association with the BCI. However, limits of agreement plots indicated important disagreement for the small proportion of observations with very high BCI. Quarter-level SCCI and BCI fluctuations were also significantly associated, and a substantial correlation (Spearman rho ranging from 0.54 to 0.58) could be seen between observed and predicted rates. Conversely, the predictive value of composite-DHI SCC for monitoring IMI incidence during the lactation seemed to be quite limited. Composite SCCI was strictly associated with major IMI BCI, showed a relatively low correlation with the observed rate (Spearman rho: 0.14), and was of little help for longitudinal monitoring of the IMI incidence.

Short communication: Relationship between herd intramammary infection incidence and elimination rate during the dry period

The objective of the study was to explore the relationship between herd dry period (DP) intramammary infection (IMI) incidence and elimination rates. A cohort of 91 Canadian dairy herds was recruited and followed in 2007 and 2008. Universal dry cow therapy was widely adopted among the participating herds. At the beginning of years 2007 and 2008, a sample of 15 cows was selected in each herd. A series of quarter-milk samples consisting of 2 predry and 2 postcalving samples were collected on each quarter of these 30 cows. Milk samples were analyzed using routine bacteriological milk culture, and predry and postcalving IMI statuses of these quarters were established using parallel interpretation of the 2 predry and 2 postcalving tests, respectively. Intramammary infection status was defined as IMI by Staphylococcus aureus, streptococci other than Streptococcus agalactiae, coagulase-negative staphylococci (CNS), or Corynebacterium spp. Incidence and elimination rates of DP IMI were computed for each herd. Lowess curves and linear regression were used to investigate the association between DP IMI incidence and elimination rates. Significant negative associations were found between incidence and elimination rates of Staph. aureus and CNS. The relationship between incidence and elimination rates was nonlinear for CNS, with a relatively strong negative relationship between DP IMI incidence and elimination rates for herds with relatively low DP IMI incidence (<0.10 new IMI/quarter-month). For herds with higher DP IMI incidence (≥0.10 new IMI/quarter-month), a weaker negative relationship was observed between rates. No significant associations could be seen between DP incidence and elimination rates of streptococci other than Strep. agalactiae and of Corynebacterium spp. These results suggest that, conversely to the general belief, acquisition of new IMI and elimination of existing IMI during the DP may be driven, at least for staphylococci, by common mechanisms. The use of management strategies that would lead to the selection of pathogens less well adapted to the host could explain the associations observed between acquisition and elimination of IMI over the DP.

Monitoring dry period intramammary infection incidence and elimination rates using somatic cell count measurements

The objective of the study was to evaluate the predictive ability of the herd dry period (DP) intramammary infection (IMI) incidence and elimination rates derived from predry and postcalving somatic cell count (SCC) measurements [quarter-level SCC and dairy herd improvement (DHI) composite-level SCC] for monitoring the herd DP IMI incidence and elimination rates. A cohort of 91 Canadian dairy herds was followed from 2007 to 2008. In each herd, a sample of 15 cows was selected each year, and a series of 2 predry and 2 postcalving quarter milk samples were collected. Routine milk bacteriological culture was conducted to identify IMI, SCC was measured on the quarter milk samples, and composite SCC of the last predry and first postcalving DHI tests were obtained. Mastitis pathogens were grouped into 3 categories: major pathogens, minor pathogens, and any pathogens. For each herd, DP bacteriological culture-derived IMI incidence and elimination rates were computed using quarter milk culture data. Similarly, SCC-derived herd incidence and elimination rates were computed using quarter and DHI composite-level SCC measurements and using various SCC thresholds to define new and eliminated IMI. Linear regression was used to compare herd quarter-level and composite-level SCC-derived herd incidence and elimination with DP bacteriological culture-derived IMI incidence and elimination. Herd DP incidences computed by using quarter-level SCC, and with most of the SCC thresholds tested, were significant predictors of the DP major, minor, and any IMI incidences (F-test; P≤0.05). The highest coefficients of determination (R2) were obtained with thresholds of 200,000 (R2: 12%) and 50,000cells/mL (R2: 25%) for predicting major and minor IMI, respectively. When using composite DHI SCC measurements, however, substantial losses of predictive power were seen for minor and any IMI incidences compared with quarter-level SCC. For DP major IMI incidence, composite SCC yielded similar, but modest, predictive power when a cutoff value of 150,000cells/mL was chosen to define new IMI. To predict DP elimination rates, the value of quarter-level SCC seemed limited to predicting the DP major IMI elimination rate. Composite SCC, on the other hand, showed modest predictive power for major and minor IMI elimination rates, with thresholds of 200,000 and 50,000cells/mL, respectively. Results from the current study suggest that quarter and composite SCC-derived rates could be used as substitutes for bacteriological culture-derived rates for some groups of mastitis pathogens.